Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition
NCT02296749
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Sirolimus
Sponsor
Dr. Reddy's Laboratories Limited